Video: Colin Cowherd, Joel Klatt Explain Why They Believe Michigan State Can Win It All

first_imgColin Cowherd previews the Big 10 Championship on The Herd.colin cowherd joel klatt high on michigan stateMichigan State has an all-important contest this Saturday, as the Spartans take on undefeated Iowa in the Big Ten title game. The contest, which is being played between the No. 4 and No. 5 ranked teams in the College Football Playoff rankings, is a de facto national quarterfinal.Thursday, FOX Sports radio host Colin Cowherd and guest Joel Klatt debated whether they believe the Spartans are capable of not just winning that game – but winning the national championship. Both do, citing Connor Cook, the team’s offensive line and the fact that they’re getting healthy at the right time.Michigan State and Iowa kick off at 8:00 PM on FOX.last_img read more

Study explores whether most patients with fibromyalgia are misdiagnosed

first_imgReviewed by James Ives, M.Psych. (Editor)Feb 6 2019Recent studies have suggested that most people who have been diagnosed with fibromyalgia by physicians may not actually have the condition. A new Arthritis Care & Research study found that overall agreement between clinicians’ diagnosis of fibromyalgia and diagnosis by published criteria is only fair.For the study, 497 patients visiting a rheumatology clinic completed a health assessment questionnaire as well as a questionnaire that assessed fibromyalgia diagnostic variables used by the American College of Rheumatology. Patients were also evaluated and diagnosed by rheumatology clinicians.Of the 497 patients, 121 (24.3 percent) satisfied fibromyalgia criteria while 104 (20.9 percent) received a clinician’s diagnosis of fibromyalgia. The agreement between clinicians and criteria was 79.2 percent; however, agreement beyond chance was only fair. Physicians failed to identify 60 (49.6 percent) of criteria-positive patients and incorrectly identified 43 (11.4 percent) of criteria-negative patients.Related StoriesMultiple breaches of injection safety practices identified in New Jersey septic arthritis outbreakAMSBIO offers new, best-in-class CAR-T cell range for research and immunotherapyTAU’s new Translational Medical Research Center acquires MILabs’ VECTor PET/SPECT/CT”We have recently studied the same issue in 3,000 primary care patients and found about the same results. Therefore, our conclusions are secure,” said lead author Dr. Frederick Wolfe, of the National Data Bank for Rheumatic Diseases.In an accompanying editorial Dr. Don Goldenberg, of Oregon Health & Science University, noted that to conclude that expert physicians often misdiagnose fibromyalgia implies that published criteria are superior to expert clinical judgement for the diagnosis of individual patients. He stressed that this fails to account for many of the variables present in clinical encounters, including time spent in evaluating and categorizing each patient’s multiple symptoms. “The diagnostic gold standard for fibromyalgia will continue to be the rheumatologist’s expert opinion, not classification criteria, no matter how well-refined and intentioned,” he wrote. “This is the only way to capture the variability and severity of inter-related symptoms as they play out over time.”Source: https://newsroom.wiley.com/press-release/arthritis-care-research/are-most-patients-fibromyalgia-misdiagnosedlast_img read more

Echocardiography may aid in patient selection for TMVR

first_imgReviewed by James Ives, M.Psych. (Editor)Mar 18 2019Clinicians should use echocardiography, an ultrasound that shows the heart’s structure and function, when determining whether patients with heart failure and a leaking heart valve are likely to benefit from valve repair, according to research presented at the American College of Cardiology’s 68th Annual Scientific Session.The new study offers additional insights on the COAPT trial, which investigated the use of a procedure called transcatheter mitral valve repair (TMVR) in patients with secondary mitral regurgitation, a condition where the mitral valve does not close properly due to problems with the heart’s pumping chambers. In 2018, COAPT researchers reported that patients undergoing TMVR with the MitraClip device had significantly better rates of survival at two years compared to those receiving standard medications alone.To help translate COAPT’s findings into practical guidance for clinical decisions, the new study details how echocardiography can be used to diagnose secondary mitral regurgitation, along with how the researchers used a multi-parametric algorithm adapted from the American Society of Echocardiography and ACC guidelines to determine which patients were eligible to participate in the study and track the valve’s function over the course of two years. While clinicians routinely use echocardiograms when assessing mitral regurgitation, there is no worldwide standard for diagnosing secondary mitral regurgitation with this tool, limiting its application. As a result, details on the study methodology are important for informing clinical practice, researchers said.”We found echocardiography is valuable for assessing patients with secondary mitral regurgitation on multiple levels,” said Federico M. Asch, MD, director of the Echocardiography Core Lab at MedStar Health Research Institute, associate professor of medicine at Georgetown University and the study’s lead author. “Echocardiography should be used to determine which patients are candidates for TMVR, and it should also be used after MitraClip implantation to see the results of the procedure.”COAPT enrolled 614 patients treated at 78 medical centers in the U.S. and Canada and randomly assigned them to receive the MitraClip or maximally tolerated medical therapy as recommended by clinical guidelines, which typically includes diuretics, beta blockers and other medications, and sometimes cardiac resynchronization therapy (a pacemaker). All participants had heart failure and moderate to severe secondary mitral regurgitation at the start of the trial. Heart failure is a condition in which the heart is too weak to pump enough blood to meet the body’s needs. Secondary mitral valve regurgitation frequently coexists with heart failure, worsens patients’ symptoms and affects their quality of life and survival.Related StoriesOlympus Europe and Cytosurge join hands to accelerate drug development, single cell researchResearch sheds light on sun-induced DNA damage and repairDon’t Miss the Blood-Brain Barrier Drug Delivery (B3DD) Summit this AugustResearchers used echocardiography to image participants’ hearts before enrollment and during follow-up visits at one, six, 12, 18 and 24 months. They developed an algorithm that was used by expert echocardiographers to interpret the heart images, evaluate the functioning of the valve and determine whether patients were appropriate candidates for the MitraClip procedure. Follow-up assessments revealed that the repaired valve was effective at preventing backward flow of blood through the valve (mitral regurgitation), and that this effect persisted throughout the two years of follow-up.In addition, the study focused on identifying characteristics of the heart, measurable with an echocardiogram, that may predict which patients would have a better or worse response to TMVR. In this analysis, researchers found that TMVR was equally beneficial across all subgroups analyzed, including the size, function or pressures of the heart’s chambers, leading them to conclude that all patients with similar characteristics to those in the trial should be considered for this intervention.”MitraClip was shown to be beneficial in the study population in all sub-groups analyzed, regardless of patients’ echocardiographic characteristics,” Asch said. “While we learned that patients with higher pulmonary hypertension are at higher risk after they receive the MitraClip, they still do better than if they would not have had the intervention done. Doing an echocardiogram is critical in determining if a patient is a good candidate for MitraClip and in following these patients to evaluate results of the procedure in the long run.” Source:https://www.acc.org/last_img read more

The leverage to stand out

first_img Education 23 Jun 2019 Newcastle teams tackle issues Nation 08 Jul 2019 Soo Wincci makes it to Malaysia Book of Records once again with two new entries With such impressive standings, graduates from Newcastle University are highly sought-after, with 95% of graduates being employed or venturing forth for future study. In fact, it is one of the top 20 universities targeted by graduate employers in the UK. Now Malaysian students who wish to study medicine and the biosciences can be part of this establish circle, in a fully-owned international campus concentrating on medicine locally in Johor. The NUMed edgeCalled Newcastle University Medicine Malaysia, or NUMed Malaysia in short, developed projects in a hub-and-spoke model with Newcastle University UK — that is research programmes done locally are shared with the UK-side as a translational and education research. Expert researchers can work in partnership to deliver high quality studies that will benefit the educational needs of students at NUMed Malaysia and health care needs of patients in South-East Asia. The impact of NUMed Malaysia’s research has contributed to some of Newcastle University’s ground-breaking discoveries, such as the development of new treatments in the field of ageing, cell and molecular biosciences, cellular medicine, health and society, genetic medicine, neurosciences and even cancer. NUMed Malaysia students are entitled for double accreditation from General Medical Council (UK) and Malaysian Medical Council.The medical and biomedical education offered at NUMed Malaysia begins at the foundation level, leading up to undergraduate degrees and postgraduate studies in clinical research, oncology and palliative care studies and postgraduate certification in medical education.Acclaimed health-related studiesNUMed Malaysia’s Foundation in Biological and Biomedical Sciences programme was designed as a 12-month pre-undergraduate foundation course for Malaysian students who wish to study medicine, biological or biomedical sciences or science at the undergraduate level at NUMed Malaysia, or in another local higher education institution, depending on their final grades. NUMed Malaysia’s five-year Bachelor of Medicine and Bachelor of Surgery (MBBS) programme is identical to that of Newcastle University, UK and offers a general medical education that is suitable for all types of doctor and serve as the foundation for later career specialisation. {{category}} {{time}} {{title}} All subjects for the whole programme are delivered in NUMed Malaysia, although students are given opportunities to study at the medical school in Newcastle during the fourth year. Its Biomedical Sciences BSc Honours is a 2+1 programme that covers a diverse range of subjects relating to medicine and is similar to the one delivered at the Newcastle University’s medical school in the UK,This programme offered at NUMed Malaysia has two academic years that mirrors the programme offered in the UK but delivered at the custom-built 5.26ha NUMed Malaysia campus in Iskandar Puteri, Johor and an academic year at the Newcastle UK campus.The postgraduate courses offered at NUMed Malaysia are e-learning programmes delivered by Newcastle University through a virtual learning environment.They include the Master of Clinical Research (MClinRes, PG Dip; PG Cert), Oncology and Palliative Care MSc studies, and the Postgraduate Certificate in Medical Education. The NUMed Malaysia focuses on medical and biomedical education at its custom-built 5.26ha campus located at Iskandar Puteri, Johor. Tags / Keywords: Sponsored , Newcastle University , NUMed Malaysia , Higher Education , Branded Students who wish to study medicine and the biosciences can be part of a fully-owned international campus concentrating on medicine locally in NUMed Malaysia, Johor, NUMed Malaysia’s research has contributed to some of Newcastle University’s ground-breaking discoveries. AS a member of the reputable Russell Group of universities well-known for intensive research, Newcastle University in the UK has been one of the leading academic institutions that attract over 27,000 students from around the world.It ranked 171 on the Times Higher Education World University Rankings last year and a global leader in ageing and health, data, energy, cities, and the creative arts. Many of its 214,000 alumni headline diverse industries, from digital technology to finance and fine art. Newcastle University stands out in its instruction in Medicine, coming in as one of the UK’s top 20 subjects areas listed in The Guardian’s University League Tables 2020.Reputable research AdChoices广告The university developed a strong and vibrant interdisciplinary research base in medicine and the physical sciences since the 19th century.Its academics and researchers have been providing solutions to some of the world’s greatest challenges, collaborating with other institutions that share a similar vision in developing new treatments or technologies. The Research Excellence Framework placed the university 16th in the UK, with 78% of its research was renowned for its high reputation. It is consistently ranked within the top three for impact excellence in areas as diverse as computing science, environmental science and English. Education 07 Jul 2019 Steady climb on world’s young universities ranking Related News Related News NUMed Malaysia is currently accepting applications for the September intake, in its Foundation in Biological and Biomedical Sciences, BSc (Hons) Biomedical Sciences (BMS), Bachelor of Medicine, Bachelor of Surgery (MBBS).Those interested can apply today, or during the NUMed Malaysia’s Open Day, held on Aug 17 and 24.For details, you can email to admissions@newcastle.edu.my, call 07-555 3800, WhatsApp to 011-1231 5411 or 012-7849456, or visit the NUMed Malaysia website.last_img read more